Retailers roll out new flu vaccines; Astellas inks cell-based vax development pact

Vaccine Market

Walgreen's has rolled out the new seasonal flu vaccine at 7,500 stores across the U.S. Report

Swelling sales of the Japanese encephalitis vaccine Ixiaro are expected to boost product sales in the second half of the year for Intercell AG. "Intercell expects enhanced vaccination recommendations and increasing global marketing and sales efforts by its partners Novartis and CSL Ltd., fostering disease and product awareness," the group says in a statement. Story

A new vaccine has gained widespread use to guard dogs against the effects of a rattlesnake bite. Report

Vaccine Research

Astellas and UMN Pharma have inked a pact to develop two cell culture-based influenza vaccines. Report

The National Institute of Allergy and Infectious Diseases is providing a $6.5 million grant to the Dana-Farber Cancer Institute to develop a universal influenza vaccine. Story

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.